November 12-14, 2018
Boston, MA
View 2018 Finalized Agenda

 

Day One
TUESDAY, NOVEMBER 13 2018

Day Two
WEDNESDAY, NOVEMBER 14 2018

07.50
Registration & Morning Coffee

08.50
Chair’s Opening Remarks

Reviewing the Landscape – A Commitment to Researching the Microbiome & Nutrition

09.00
More than a Crap Shoot…Placing Bets on Enteric Health for Healthy Growth & Development in the Developing World

  • Chris Damman MD, Program Officer, Bill and Melinda Gates Foundation

Synopsis

  • Understanding the four domains of gut dysfunction will will help refine our approach to interventions that address poor growth and development in the developing world
  • In a simplistic model, the four interdependent domains of gut health are the microbiome, epithelium (barrier function and absorption), immune system (inate and adaptive), and metabolism
  • We hypothesize that the most effective preventative measures and therapies will need to address multiple gut helath domains simultaneously, and that nutritional interventions are particularly well poised for this purpose

09.30
Exploiting Mechanism of Action to Develop Probiotics with Desired Health Benefits

Synopsis

  • Microbial metabolites and their known biological activates
  • Microbial surface molecules and their known biological activities
  • Anti-inflammatory mechanism of action of exopolysaccharide expressing Bifidobacteria
  • Isolation of Short Chain Fatty Acid producing bacterial strains

10.00
Setting New Industry Standards for Probiotic Discovery & Development

Synopsis

  • Building a platform that combines clinical trial data, cell line testing, WGS insights and GI simulation models to develop breakthrough nutritional products
  • Exploring a ‘microbe-systems’ approach with benefits in digestive health, immune function, reproductive health and gut barrier integrity
  • Demonstrating new standards in pro- and prebiotic product development

10.30
Panel Discussion: What Are the Biggest Challenges/Opportunities for the Nutrition Space When Reviewing Microbiome Science for Product Development?

  • Raja Dhir Co-Founder & Co-CEO, Seed, Inc.
  • Mike Janusz Principal Scientist, Procter & Gamble
  • Chris Damman MD, Program Officer, Bill and Melinda Gates Foundation

10.30
Panel Discussion: What are the biggest challenges/opportunities for the nutrition space when reviewing microbiome science for product development?

  • Chris Damman MD, Program Officer, Bill and Melinda Gates Foundation
  • Mike Janusz Principal Scientist, Procter & Gamble
  • Raja Dhir Co-Founder & Co-CEO, Seed, Inc.

11.00
Speed Networking & Morning Refreshments

Next Generation Metagenomics & Bioinformatics – Choosing the Right Strains to Maintain Health

12.00
The Essential Ingredients for Decoding the Microbiome with Metabolomics

Synopsis

  • Improving mechanistic understanding to enhance practical use of information
  • An illustration to show how metabolites broker important microbe-host interactions
  • Showing metabolomics as a tool to enrich insights into interaction associations

The Gut Microbiome’s Role in GI, Metabolic & Immune Health Introduction

12.15
Presentation Title TBC, Please Check Back With Us Soon

12.45
Rehab After Antibiotic Use

Synopsis

  • Antibiotics are essential for infections and some prevention
  • Gut and microbiome role in metabolic and immune function
  • Now that we know the role that microbiome and gut plays in health, we have to consider the effect antibiotics have
  • We have rehab for surgery and it is time for us to implement the same strategy post antibiotic to assist in the recovery of the gut

13.15
Lunch & Networking

14.15
Modulation and Increasing Diversity of the Human Microbiome by Therapeutic Bacillus Endospores

Synopsis

  • Showing the ability of bacillus endospores to competitively exclude pathogenic bacteria in the human microbiome
  • Demonstrating a breakthrough study that shows the use of a bacillus endospore to positively shift the gut microbiotain a favourable manner
  • Addressing the function of these keystone species in the microbiome

14.45
The Soil Grows the Garden: Creating Products That Shift the Digestive Eco-System and Facilitate Long-Term Microbiome Change

Synopsis

  • How hybridization and processed food has dramatically altered the landscape of the digestive micro-biome and digestive tract health
  • Probiotic supplementation interventions have profound limitations in long-term microbiome shifts
  • Using the systems and products that created the problems to disseminate the antidote

15.15
Using Scientific Techniques to Design Probiotic Strains with Improved Functionality

15.45
Afternoon Break & Networking

Personalized Nutrition & the Microbiome

16.15
Machine Learning in the Microbiome: Providing Predictable Personalized Nutrition based on Your Gut

Synopsis

  • Developing and commercializing an algorithm that predicts blood sugar responses based on the unique diversity of the gut microbiome
  • Outlining an effective strategy to reduce blood sugar levels for individuals in the USA
  • Creating new insights to address and treat metabolic disorders through microbiomebased diagnostics/therapeutics

16.45
Producing Precision Probiotics Based on Your Microbiome Signature

17.15
Personalized Information about your Microbiome to Increase Health

17.45
Comfort Break

End of Day Roundtable Discussions

18.00
End of Day Roundtable Discussions Include:

Synopsis

1.The Future of Probiotics to Improve Healthfulness of Foods

Miguel Freitas
VP Health Affairs
Danone

2. Translating Brands into Products

Alan Murray
CEO
NextFoods

3. Reviewing Current Definitions of Pro- and Prebiotics

Noah Voreades
Consultant
GenBiome Consulting

 

18.20
Chairperson Closing Remarks

Close of Conference Day One & Evening Drinks Reception Hosted by The Microbiome Movement